ClinicalTrials.Veeva

Menu

Real World Observational Study of Sotatercept for Pulmonary Hypertension

Mayo Clinic logo

Mayo Clinic

Status

Invitation-only

Conditions

Pulmonary Hypertension

Study type

Observational

Funder types

Other

Identifiers

NCT06751082
24-011370

Details and patient eligibility

About

The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults age 18 or greater who are being treated with sotatercept in the Mayo Pulmonary hypertension clinic.

Exclusion criteria

  • Adults lacking capacity to consent

Trial contacts and locations

1

Loading...

Central trial contact

Hayden Halbach, M.B.A.; Louise Durst, R.N.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems